Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
12/2009
12/30/2009EP2138485A1 Substituted N-Oxide pyrazine derivatives
12/30/2009EP2137178A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
12/30/2009CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
12/30/2009CA2728680A1 Substituted n-oxide pyrazine derivatives
12/30/2009CA2728161A1 Therapeutic agent for inflammatory bowel disease
12/30/2009CA2728089A1 Therapeutic agent for spinal canal stenosis
12/29/2009US7638629 4-Isopropylphenyl)-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid; modulators of gamma secretase isoforms, 1-42; antifibrillatory agents; neurodegenerative diseases; modulating activity of gamma -secretase as opposed to suppressing it to reduced risk of side effects; beta secretase inhibitors
12/29/2009US7638627 Imatinib hydrochloride; reacting N-(2-methyl-5-aminophenyl-4-(3-pyridyl)-2-pyrimidineamine with 4-(4-methyl-piperazinomethyl)benzoyl chloride; improved reduction step to simplify, increase yield, improve purity
12/29/2009US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors
12/29/2009US7638512 Phenylaminopropanol derivatives and methods of their use
12/29/2009CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors
12/29/2009CA2370250C Di-aryl acid derivatives as ppar receptor ligands
12/24/2009US20090318697 Process for preparing a piperazine derivative
12/24/2009US20090318696 Synthesis and use of MSE-framework type molecular sieves
12/24/2009US20090318684 Rock inhibitors and uses thereof
12/24/2009US20090318473 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
12/24/2009US20090318472 Aminopyrazine derivatives and compositions
12/24/2009US20090318461 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl) benzenesulfonic acid
12/24/2009US20090318455 Compounds and methods for treating inflammatory and fibrotic disorders
12/24/2009US20090318421 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
12/24/2009US20090318389 Agonists of the sphingosine-1 phosphate receptor
12/24/2009US20090315022 Azaindenofluorenedione derivative, material for organic electroluminescence device and organic electroluminescence device
12/23/2009WO2009154246A1 Therapeutic agent for erectile dysfunction
12/23/2009WO2009152909A1 Quinoxalinedione derivatives
12/23/2009EP2135863A1 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
12/23/2009EP2134687A1 Piperazine and piperidine mglur5 potentiators
12/23/2009EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
12/23/2009CN101610772A Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
12/23/2009CA2728018A1 Quinoxalinedione derivatives
12/22/2009US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide
12/22/2009US7635698 Compounds useful as chemokine receptor antagonists
12/22/2009US7635697 e.g. 3-Bromo-8,11-dichloro-6,11-dihydro[5,6]cyclohepta[1,2-b]pyridine deivative; anticarcinogenic agents
12/22/2009CA2305803C Crystalline antifungal polymorph
12/17/2009WO2009150109A1 Imidazolidine derivatives
12/17/2009US20090312424 Aromatic prodrugs of propofol, compositions and uses thereof
12/17/2009US20090312344 Arylpiperazine derivatives as adrenergic receptor antagonists
12/17/2009US20090312328 Sulfonamide compound or salt thereof
12/17/2009US20090312315 Pai-1 inhibitor
12/17/2009CA2725654A1 Imidazolidine derivatives
12/16/2009CN101605767A Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
12/16/2009CN101602737A Benzenesulfonyl quinoxaline compound and preparation method and application thereof
12/16/2009CN101602736A Synthesis method of quizalofop-p-ethyl
12/16/2009CN101602735A Preparation method of ligustrazine
12/15/2009US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS
12/15/2009US7632838 11-beta HSD1 inhibitors
12/15/2009US7632485 Catalytic radiofluorination
12/15/2009CA2374580C Oligomers and polymers of cyclic imino carboxylic acids
12/10/2009WO2009111623A3 Amorphous varenicline tartrate
12/10/2009WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity
12/10/2009US20090306382 Cationic alkoxyamines
12/10/2009US20090306092 Method for treating cognitive deficits
12/10/2009US20090306085 Hcv protease inhibitors and uses thereof
12/09/2009EP2129653A2 Novel p2y12 receptor antagonists
12/09/2009EP1994012B1 Novel tricyclic dihydropyrazines as potassium channel openers
12/09/2009EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009EP1182183B1 Anthracene derivatives and organic electroluminescent devices made by using the same
12/09/2009CN101597266A Synthesis of nickel-ion artificial antigen chelant and preparation of nickel monoclonal antibody
12/09/2009CN100567268C Process for synthesis of amine ethers from secondary amino oxides
12/08/2009US7629460 Dihydropteridione derivatives, process for their manufacture and their use as medicament
12/08/2009US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
12/08/2009US7629341 Human ADAM-10 inhibitors
12/08/2009CA2374898C Pyrazinyl-piperazine compounds, their use and preparation
12/08/2009CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
12/03/2009WO2009145591A2 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof
12/03/2009WO2009145590A2 Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof
12/03/2009WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009WO2009145219A1 Therapeutic agent for alzheimer's disease
12/03/2009WO2009108657A3 Heteroaryl derivatives as cftr modulators
12/03/2009WO2009095872A3 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
12/03/2009WO2008139235A8 Novel piperazine salts as d3/d2 antagonists
12/03/2009US20090299067 New synthesis of 2,6-diamino-3,5-dinitropyrazine-1-oxide from 2,6-diaminopyrazine-1-oxide
12/03/2009US20090299064 Methods and intermediates for the preparation of optionally radio-labeled imatinib
12/03/2009US20090299063 Inhibitors for Extracellular Signal-Regulated Kinase Docking Domains and Uses Therefor
12/03/2009US20090298853 Carbamoyl Compounds as DGAT1 Inhibitors 190
12/03/2009US20090298851 Phenyl piperazine compounds, pharmaceutical composition comprising the same and use thereof
12/03/2009US20090298845 Piperazinyl derivatives as modulators of chemokine receptor activity
12/03/2009US20090298842 Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
12/03/2009US20090298831 Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
12/03/2009US20090298819 Compositions, Synthesis, And Methods Of Using Piperazine Based Antipsychotic Agents
12/03/2009US20090297414 Hindered cyclic polyamines and their salts for acid gas scrubbing process
12/03/2009CA2729812A1 Therapeutic agent for alzheimer's disease
12/03/2009CA2725563A1 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof
12/03/2009CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/02/2009EP2125756A1 Phenazine compounds and use thereof in autoimmune and inflammatory diseases
12/02/2009EP1515950B1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
12/02/2009EP1490346B1 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
12/02/2009EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009CN100564364C Method for integrally extracting and purifying ligustrazine, ferulic acid and volatile oil in ligusticum wallichii
12/02/2009CN100564363C Method for refining dexrazoxane
12/02/2009CN100564341C A method for inhibiting polymerization of (meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor
12/01/2009US7626042 O-substituted hydroxyaryl derivatives
12/01/2009US7626024 Processes and intermediates for the preparations of prostaglandins
12/01/2009US7626023 Compounds for treating tumors
12/01/2009US7626022 Method for producing β-heteroaryl-α-alanine compounds using 2-amino-2-(heteroarylmethyl) carboxylic acid compounds
12/01/2009US7626019 Antiproliferative agents
12/01/2009US7625938 Substituted pyrazoles, compositions containing such compounds and methods of use
12/01/2009US7625917 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein
12/01/2009US7625904 Methods for the treatment of sleep disorders
12/01/2009US7625899 antiproliferative, antitumor and anticarcinogenic agent; cyclin dependent kinase inhibitor
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 187